Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.

Leone G, Orlando F, Dutey-Magni P, Vainauskas O, Grist E, Ciani Y, Lall S, Thakali S, Wingate A, Wetterskog D, Sachdeva A, Sydes MR, McPhail N, Sreenivasan T, O'Sullivan JM, Clarke NW, Parmar MKB, Brown LC, James ND, Demichelis F, Attard G, STAMPEDE collaborators

Open source

DOI: 10.1001/jamaoncol.2024.7051
Published: 2025 Feb 27
Container: JAMA oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamaoncol.2024.7051,
  title = {Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.},
  author = {Leone G and Orlando F and Dutey-Magni P and Vainauskas O and Grist E and Ciani Y and Lall S and Thakali S and Wingate A and Wetterskog D and Sachdeva A and Sydes MR and McPhail N and Sreenivasan T and O'Sullivan JM and Clarke NW and Parmar MKB and Brown LC and James ND and Demichelis F and Attard G and STAMPEDE collaborators},
  year = {2025},
  journal = {JAMA oncology},
  doi = {10.1001/jamaoncol.2024.7051},
  url = {https://doi.org/10.1001/jamaoncol.2024.7051}
}

RIS

TY  - JOUR
TI  - Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
AU  - Leone G
AU  - Orlando F
AU  - Dutey-Magni P
AU  - Vainauskas O
AU  - Grist E
AU  - Ciani Y
AU  - Lall S
AU  - Thakali S
AU  - Wingate A
AU  - Wetterskog D
AU  - Sachdeva A
AU  - Sydes MR
AU  - McPhail N
AU  - Sreenivasan T
AU  - O'Sullivan JM
AU  - Clarke NW
AU  - Parmar MKB
AU  - Brown LC
AU  - James ND
AU  - Demichelis F
AU  - Attard G
AU  - STAMPEDE collaborators
PY  - 2025
JO  - JAMA oncology
DO  - 10.1001/jamaoncol.2024.7051
UR  - https://doi.org/10.1001/jamaoncol.2024.7051
ER  -

APA

G, L., F, O., P, D., O, V., E, G., Y, C., S, L., S, T., A, W., D, W., A, S., MR, S., N, M., T, S., JM, O., NW, C., MKB, P., LC, B., ND, J., F, D., G, A., & collaborators, S. (2025). Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.. JAMA oncology. https://doi.org/10.1001/jamaoncol.2024.7051

Source records

pubmed · retrieved 2026-09-25T14:22:10.530Z